Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Hanbo Chen
Affiliation
University of Toronto
ORCID
Career Start Year
2010
Papers
64
H Index
17
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36219521
Chemical Exchange Saturation Transfer MRI for Differentiating Radiation Necrosis From Tumor Progression in Brain Metastasis-Application in a Clinical Setting.
J Magn Reson Imaging
2023
37640160
Diffusion-weighted imaging on an MRI-linear accelerator to identify adversely prognostic tumour regions in glioblastoma during chemoradiation.
Radiother Oncol
2023
37602655
Outcomes for oligometastatic head and neck cancer treated with stereotactic body radiotherapy: Results from an international multi-institutional consortium.
Head Neck
2023
37256526
Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis.
J Neurooncol
2023
37155133
Stereotactic body radiotherapy for spine metastases: a review of 24 Gy in 2 daily fractions.
J Neurooncol
2023
37385379
The impact of local control on widespread progression and survival in oligometastasis-directed SBRT: Results from a large international database.
Radiother Oncol
2023
37414253
Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastases.
Radiother Oncol
2023
37378836
Correction to: Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis.
J Neurooncol
2023
36997023
Stereotactic Body Radiation Therapy for Posterior Element-Only Spinal Metastases: A First Report on Outcomes and Validation of Recommended Clinical Target Volume Delineation Practice.
Pract Radiat Oncol
2023
36852015
Ensuring Superior Reporting of Radiation Therapy Noninferiority Trials: A Systematic Review.
Adv Radiat Oncol
2023
36914878
Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS).
J Neurooncol
2023
36493331
Mepitel Film for the Prevention of Acute Radiation Dermatitis in Breast Cancer: A Randomized Multicenter Open-Label Phase III Trial.
J Clin Oncol
2023
33276151
Epidemiology of bone metastases.
Bone
2022
35753554
Conditional Survival of Patients With Extracranial Oligometastatic Treated With Stereotactic Body Radiation Therapy: An International Consortium Study.
Int J Radiat Oncol Biol Phys
2022
35715667
Trastuzumab emtansine increases the risk of stereotactic radiosurgery-induced radionecrosis in HER2â¿¿+â¿¿breast cancer.
J Neurooncol
2022
36518316
High grade glioma radiation therapy on a high field 1.5 Tesla MR-Linac - workflow and initial experience with daily adapt-to-position (ATP) MR guidance: AÂ first report.
Front Oncol
2022
36001229
A deep learning model with incorporation of microvascular invasion area as a factor in predicting prognosis of hepatocellular carcinoma after R0 hepatectomy.
Hepatol Int
2022
36203028
Proposing a quantitative MRI-based linear measurement framework for response assessment following stereotactic body radiation therapy in patients with spinal metastasis.
J Neurooncol
2022
34890753
Development of a Prognostic Model for Overall Survival in Patients With Extracranial Oligometastatic Disease Treated With Stereotactic Body Radiation Therapy.
Int J Radiat Oncol Biol Phys
2022
34952002
An analysis of a large multi-institutional database reveals important associations between treatment parameters and clinical outcomes for stereotactic body radiotherapy (SBRT) of oligometastatic colorectal cancer.
Radiother Oncol
2022
34981300
Inter-fraction dynamics during post-operative 5 fraction cavity hypofractionated stereotactic radiotherapy with a MR LINAC: a prospective serial imaging study.
J Neurooncol
2022
35306442
Deep contrastive learning based tissue clustering for annotation-free histopathology image analysis.
Comput Med Imaging Graph
2022
34927313
Stereotactic radiotherapy as planned boost after definitive radiotherapy for head and neck cancers: Systematic review.
Head Neck
2022
34673275
Stereotactic Radiosurgery for Postoperative Spine Malignancy: A Systematic Review and International Stereotactic Radiosurgery Society Practice Guidelines.
Pract Radiat Oncol
2022
33068687
Quantitating Interfraction Target Dynamics During Concurrent Chemoradiation for Glioblastoma: A Prospective Serial Imaging Study.
Int J Radiat Oncol Biol Phys
2021
33714691
Immunotherapy and Stereotactic Ablative Radiotherapy for Lung Cancer with Co-existing Interstitial Lung Disease: A Case Report.
Clin Lung Cancer
2021
33526778
Addendum: Early triage of critically ill COVID-19 patients using deep learning.
Nat Commun
2021
34616754
The Epidemiology of Lung Metastases.
Front Med (Lausanne)
2021
34668651
Volumetric burden of metastatic lesions drives outcomes in patients with extracranial oligometastatic disease.
Cancer Med
2021
34584809
Characterizing Surgical and Radiotherapy Outcomes in Non-metastatic High-Risk Prostate Cancer: A Systematic Review and Meta-Analysis.
Cureus
2021
34432390
Late metastatic presentation is associated with improved survival and delayed wide-spread progression after ablative stereotactic body radiotherapy for oligometastasis.
Cancer Med
2021
34454974
An international pooled analysis of SBRT outcomes to oligometastatic spine and non-spine bone metastases.
Radiother Oncol
2021
34392364
The Initial Step Towards Establishing a Quantitative, Magnetic Resonance Imaging-Based Framework for Response Assessment of Spinal Metastases After Stereotactic Body Radiation Therapy.
Neurosurgery
2021
34592363
Accuracy and precision of apparent diffusion coefficient measurements on a 1.5Â T MR-Linac in central nervous system tumour patients.
Radiother Oncol
2021
34018490
A pilot study of everolimus and radiation for neuroendocrine liver metastases.
Endocr Relat Cancer
2021
34343546
Impact of daily plan adaptation on organ-at-risk normal tissue complication probability for adrenal lesions undergoing stereotactic ablative radiation therapy.
Radiother Oncol
2021
34280403
Chemical exchange saturation transfer MRI in central nervous system tumours on a 1.5Â T MR-Linac.
Radiother Oncol
2021
34330566
Stereotactic ablative radiotherapy in T1-2N0M0 small cell lung cancer: A systematic review and meta-analysis.
Lung Cancer
2021
33196965
Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiation.
J Neurooncol
2021
32402471
High risk, same reward?
Lung Cancer
2020
33665492
Stereotactic Radiation Therapy for De Novo Head and Neck Cancers: A Systematic Review and Meta-Analysis.
Adv Radiat Oncol
2020
32739318
Changes in gastric anatomy after delivery of breath-hold MR-guided SABR for adrenal metastases.
Radiother Oncol
2020
32760673
Current Management and Progress in Radiotherapy for Small Cell Lung Cancer.
Front Oncol
2020
32669540
Early triage of critically ill COVID-19 patients using deep learning.
Nat Commun
2020
32420074
Is lung stereotactic ablative radiotherapy safe after pneumonectomy?-a systematic review.
Transl Lung Cancer Res
2020
32363344
Epidemiology of synchronous brain metastases.
Neurooncol Adv
2020
32562887
Epidemiology of liver metastases.
Cancer Epidemiol
2020
32544575
Is There a Role for Hypofractionated Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer? A Propensity Score Matched Analysis.
Int J Radiat Oncol Biol Phys
2020
31075543
Safety and Effectiveness of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Lesions: A Systematic Review.
J Thorac Oncol
2019
31829203
Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial.
BMC Cancer
2019
1 - 50 of 64
Column Actions
Search
Recommended Authors
Luca F Valle
University of California los angeles
Career Start Year
2016
Number of shared co-authors
3
Erqi L Pollom
Stanford University
Career Start Year
2014
Number of shared co-authors
3
Soumyajit Roy
Rush University Medical Center
Career Start Year
2013
Number of shared co-authors
3
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year
2013
Number of shared co-authors
12
Darlene Veruttipong
Stanford University
Career Start Year
2012
Number of shared co-authors
0
Nikhil T Sebastian
Emory University
Career Start Year
2011
Number of shared co-authors
0
Matthew P Deek
Rutgers Robert Wood Johnson Medical School, Rutgers University
Career Start Year
2011
Number of shared co-authors
4
Joseph Sia
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year
2011
Number of shared co-authors
3
Ting Martin Ma
University of Washington
Career Start Year
2010
Number of shared co-authors
3
Rebecca Levin-Epstein
University of California los angeles
Career Start Year
2010
Number of shared co-authors
3
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year
2009
Number of shared co-authors
1
Tai-Chung Lam
University of Hong Kong
Career Start Year
2008
Number of shared co-authors
0
Steven H Lin
University of Texas MD Anderson Cancer Center
Career Start Year
2008
Number of shared co-authors
3
Michael Xiang
University of California los angeles
Career Start Year
2007
Number of shared co-authors
3
Cary Oberije
Maastricht University Medical Centre
Career Start Year
2005
Number of shared co-authors
5
Daniel R Gomez
Memorial Sloan Kettering Cancer Center
Career Start Year
2005
Number of shared co-authors
2
Joost J C Verhoeff
University Medical Center Utrecht
Career Start Year
2005
Number of shared co-authors
2
Esther G C Troost
German Cancer Research Center (DKFZ)
Career Start Year
2003
Number of shared co-authors
3
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year
2001
Number of shared co-authors
1
Chandana A Reddy
Cleveland Clinic
Career Start Year
2000
Number of shared co-authors
6
Drew Moghanaki
University of California Los Angeles
Career Start Year
2000
Number of shared co-authors
1
Chiaojung Jillian Tsai
Memorial Sloan Kettering Cancer Center
Career Start Year
2000
Number of shared co-authors
4
Steve E Braunstein
University of California san francisco
Career Start Year
1998
Number of shared co-authors
1
Puneeth Iyengar
UT Southwestern Medical Center, Center for Human Nutrition
Career Start Year
1996
Number of shared co-authors
2
Michael L Steinberg
University of California los angeles
Career Start Year
1996
Number of shared co-authors
4
Cheryl Ho
University of British Columbia
Career Start Year
1995
Number of shared co-authors
3
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year
1994
Number of shared co-authors
7
Dirk De Ruysscher
Maastro Clinic
Career Start Year
1983
Number of shared co-authors
9
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year
1982
Number of shared co-authors
3
John P Kirkpatrick
Duke University Medical Center
Career Start Year
1978
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
David A Palma
University of Western Ontario
Co-authored papers
8
Andrew Warner
Western University and London Regional Cancer Program
Co-authored papers
5
Nir Lipsman
University of Toronto
Co-authored papers
5
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Co-authored papers
4
Paul C Boutros
University of California los angeles
Co-authored papers
3
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Co-authored papers
2
Wei-Jie Guan
The Second Affiliated Hospital of Xiamen Medical College
Co-authored papers
2
Zisheng Chen
The Sixth Affiliated Hospital of Guangzhou Medical University
Co-authored papers
2
Nuofu Zhang
National Clinical Research Center for Respiratory Disease Guangzhou
Co-authored papers
2
Hengrui Liang
The First Affiliated Hospital of Guangzhou Medical University
Co-authored papers
2
Wenhua Liang
The First People's Hospital of Zhaoqing
Co-authored papers
2
Ling Sang
the First Affiliated Hospital of Guangzhou Medical University
Co-authored papers
2
Yimin Li
The First Affiliated Hospital of Guangzhou Medical University
Co-authored papers
2
Yuanda Xu
the First Affiliated Hospital of Guangzhou Medical University
Co-authored papers
2
Jianxing He
Guangzhou Medical University, First Hospital
Co-authored papers
2
Shiyue Li
Guangzhou Respiratory Institute
Co-authored papers
2
Yi Zhao
the First Affiliated Hospital of Guangzhou Medical University
Co-authored papers
2
Ailan Chen
the First Affiliated Hospital of Guangzhou Medical University
Co-authored papers
2
Nanshan Zhong
Kunming University of Science and Technology
Co-authored papers
2
Dominique Trudel
Institut du cancer de Montreal
Co-authored papers
1
Lauren C Chong
University of British Columbia
Co-authored papers
1
Ada Wong
University Health Network
Co-authored papers
1
Daryl Waggott
Ontario Institute for Cancer Research
Co-authored papers
1
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers
1
Robert G Bristow
University of Toronto
Co-authored papers
1
Natalie S Fox
University of California los angeles
Co-authored papers
1
Timothy Beck
Human Longevity Inc.
Co-authored papers
1
Faraz Hach
University of British Columbia
Co-authored papers
1
Gaetano Zafarana
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
1
Fouad Yousif
Ontario Institute for Cancer Research
Co-authored papers
1
1 - 30